Cardiac resynchronization therapy: state of the art 2013
Authors:
Open Access
- 25 January 2013
- journal article
- review article
- Published by Oxford University Press (OUP) in European Heart Journal
- Vol. 34 (19) , 1396-1403
Abstract
Cardiac resynchronization therapy (CRT) is currently an established device therapy for heart failure (HF) patients. Cumulated knowledge on the pathophysiological mechanisms, implantation techniques, advancement of device-based technologies, and clinical trial experience has impacted on this evolving therapy significantly in the last few years. This article will address the updated CRT guideline and potentially new indications of CRT such as patients with New York Heart Association Class I, normal QRS duration, and non-HF patients with pacing indications. Furthermore, important but unresolved issues will also be discussed which include the impact of QRS morphology and QRS duration on CRT response, new approaches for placement of left ventricular (LV) lead, multisite LV pacing, and the role of HF disease monitoring program.Keywords
This publication has 57 references indexed in Scilit:
- The Benefit of Cardiac Resynchronization Therapy and QRS Duration: A Meta‐AnalysisJournal of Cardiovascular Electrophysiology, 2011
- Effectiveness of Cardiac Resynchronization Therapy by QRS Morphology in the Multicenter Automatic Defibrillator Implantation Trial–Cardiac Resynchronization Therapy (MADIT-CRT)Circulation, 2011
- 2010 Focused Update of ESC Guidelines on device therapy in heart failure: An update of the 2008 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure and the 2007 ESC guidelines for cardiac and resynchronization therapy Developed with the special contribution of the Heart Failure Association and the European Heart Rhythm AssociationEuropean Heart Journal, 2010
- Prevention of Disease Progression by Cardiac Resynchronization Therapy in Patients With Asymptomatic or Mildly Symptomatic Left Ventricular DysfunctionJACC, 2009
- Cardiac-Resynchronization Therapy for the Prevention of Heart-Failure EventsNew England Journal of Medicine, 2009
- Randomized Trial of Cardiac Resynchronization in Mildly Symptomatic Heart Failure Patients and in Asymptomatic Patients With Left Ventricular Dysfunction and Previous Heart Failure SymptomsJACC, 2008
- ACC/AHA/HRS 2008 Guidelines for Device-Based Therapy of Cardiac Rhythm AbnormalitiesJACC, 2008
- Guidelines for cardiac pacing and cardiac resynchronization therapy: The Task Force for Cardiac Pacing and Cardiac Resynchronization Therapy of the European Society of Cardiology. Developed in Collaboration with the European Heart Rhythm AssociationEP Europace, 2007
- Cardiac Resynchronization Therapy in Patients With a Narrow QRS ComplexJACC, 2006
- High prevalence of left ventricular systolic and diastolic asynchrony in patients with congestive heart failure and normal QRS durationHeart, 2003